Elsevier

Cellular Immunology

Volume 192, Issue 2, 15 March 1999, Pages 87-95
Cellular Immunology

Regular Article
A Specific Inhibitor of the p38 Mitogen Activated Protein Kinase Affects Differentially the Production of Various Cytokines by Activated Human T Cells: Dependence on CD28 Signaling and Preferential Inhibition of IL-10 Production

https://doi.org/10.1006/cimm.1998.1448Get rights and content

Abstract

Cytokine production upon T cell activation results from the integration of multiple signaling pathways from TCR/CD3 and from costimulatory molecules such as CD28. Among these pathways, the possible role of p38 mitogen activated protein kinase (MAPK) is the least understood. Here, we used a highly specific p38 MAPK inhibitor, the SB203580 compound, to examine the role of this enzyme in the induction of various cytokines in human T cells stimulated with anti-CD3 and anti-CD28 mAb together or in combination with PMA. Cytokine induction was monitored by ELISA and at the mRNA level. While SB203580 had little effect on IL-2 production and proliferation, it significantly reduced the production of several other cytokines. The secretion of IL-4, IL-5, IL-13, and TNF-α was inhibited by 20–50% with modes of T cell activation involving the CD28 pathway, whereas their mRNA expression was little affected. In contrast, IFN-γ induction via CD28/PMA or CD3/CD28, but not CD3/PMA, was markedly diminished both at the protein and at the mRNA levels. Most interestingly, SB203580 also suppressed IL-10 secretion and mRNA induction via CD28-dependent activation by 75–85% (IC50∼0.2 μM). Subset analysis suggested that this inhibition did not reflect a differential effect on T cell subsets. Therefore, p38 MAPK activity appears to contribute to cytokine production, mostly via CD28-dependent signaling. Moreover, IL-10 seems to rely more on this activity than other cytokines for its induction in T cells.

References (43)

  • C.E. Rudd

    Immunity

    (1996)
  • A. Paul et al.

    Cell Signal.

    (1997)
  • M. Faris et al.

    J. Biol. Chem.

    (1996)
  • Y. Chu et al.

    J. Biol. Chem.

    (1996)
  • D.R. DeSilva et al.

    Cell. Immunol.

    (1997)
  • A. Cuenda et al.

    FEBS Lett.

    (1995)
  • S. Kumar et al.

    Biochem. Biophys. Res. Commun.

    (1997)
  • P.R. Young et al.

    J. Biol. Chem.

    (1997)
  • A. Clerk et al.

    FEBS Lett.

    (1998)
  • P. Cohen

    Trends Cell Biol.

    (1997)
  • S. Matsuda et al.

    J. Biol. Chem.

    (1998)
  • R.H. Schwartz

    Curr. Opin. Immunol.

    (1997)
  • J.B. Crawley et al.

    J. Biol. Chem.

    (1997)
  • J.L. Kelly et al.

    Surgery

    (1997)
  • J. Alberola-Ila et al.

    Annu. Rev. Immunol.

    (1997)
  • A. Rao et al.

    Annu. Rev. Immunol.

    (1997)
  • E. Genot et al.

    EMBO J.

    (1996)
  • J.C. Lee et al.

    Nature

    (1994)
  • C.E. Whitehurst et al.

    J. Immunol.

    (1996)
  • M. Egerton et al.

    Eur. J. Immunol.

    (1996)
  • F.J. Dumont et al.

    J. Immunol.

    (1998)
  • Cited by (0)

    View full text